Global Projects Move Genomic Medicine to the Next Level
-
Upload
hannes-smarason -
Category
Health & Medicine
-
view
190 -
download
1
description
Transcript of Global Projects Move Genomic Medicine to the Next Level
Global Projects Move Genomic Medicine to the Next Level
Hannes Smarason Genome Sequencing |Personalized Medicine | Transforming Health Care
The Next Level in Genomic Medicine New genomics-‐based technologies and tools are making their way into a range of exci@ng research programs and clinical studies around the world. Leading-‐edge organiza@ons are quickly adop@ng hardware for sequencing and systems for collec@ng genomic data. Now, the focus has turned to analysis and interpreta@on – the cri@cal component necessary to gain the insights from the sequence data that will transform medicine.
Global Projects Employing Sequencing • Earlier this year, Genomics England announced investments
for broad sequencing and analysis of 100,000 human genomes.
• At the @me, Genomics England had selected Illumina as its sequencing partner and was coordina@ng resources and centers to support the effort, including resourcing for analysis and interpreta@on. [See blog post here.]
• Other ini@a@ves, such as the Qatar genomics program and the ini@a@ves by Longevity and Regeneron also represent the accelerated progress in seeking medical advancements from genomic data insights. [See blog post here.]
Genomics England Turns to Data Analysis
• This week, Genomics England announced a select group of companies with advanced capabili@es to move to the next stage of evalua@on to provide clinical interpreta@on for the 100K Genomes Project.
• At the @p top was NextCODE, which received top marks by Genomics England for its analy@cal capabili@es across all the categories evaluated: rare disease interpreta@on, secondary pipeline analysis and cancer interpreta@on.
[See release here.]
NextCODE Technology on Top • The company’s advanced Genomically-‐Ordered Rela@onal
database, or GOR, combined with its clinical and discovery interfaces offer the most advanced and reliable capabili@es to support the ambi@ous tasks undertaken by Genomics England, and are already proven at popula@on scale. [Read more on the GOR database here.]
The coming months will be a very exci@ng @me for genomic medicine, with interpreta@on taking the spotlight as we take leaps toward the next stage of personalized medicine. Read more about NextCODE’s work here.
ExciFng Times Ahead